Pradaxa

Pradaxa is a blood thinning drug made by Boehringer Ingelheim a. More than 4,000 people suffered bleeding – including gastrointestinal, rectal and brain bleeding. Lawsuits were filed against the manufacturer. The drug Pradaxa was marketed heavily to doctors in the United States. Those doctors wrote millions of prescriptions for the drug after the Food and Drug Administration (FDA) approved it in October 2010.

More that 540 Pradaxa users lost their lives in 2011 and many more reported suffering serious side effects. In May of 2014, the manufacturer Boehringer Ingelheim agreed to pay $650 million to settle the 4,000 state and federal lawsuits for the drug Pradaxa.